Psyence Biomedical Ltd. (PBM) EPS (Basic) (2023 - 2025)
Psyence Biomedical (PBM) posted quarterly EPS (Basic) of -$6.35 for Q3 2025, down 124.93% year-over-year from $25.47 in Q3 2024, and down 124.93% quarter-over-quarter from $25.47 in Q3 2024.
Psyence Biomedical Ltd. (PBM) EPS (Basic) (2023 - 2025) Analysis & Trends
Psyence Biomedical's EPS (Basic) history runs 3 years deep, the most recent figure standing at -$6.35 for Q3 2025.
- In Q3 2025, EPS (Basic) fell 124.93% year-over-year to -$6.35; the TTM figure through Mar 2026 stood at -$2.47 (up 54.67% YoY), while the FY2026 annual figure was -$12.48, up 89.47% from the prior year.
- EPS (Basic) for Q3 2025 stood at -$6.35, down from $25.47 in the prior quarter.
- The five-year high for EPS (Basic) was $25.47 in Q3 2024, with the low at -$2417.7 in Q1 2023.
- The 3-year median for EPS (Basic) is -$91.71 (2025), against an average of -$643.91.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) soared 114.38% in 2024, then plunged 124.93% in 2025.
- Psyence Biomedical's EPS (Basic) stood at -$177.06 in 2023, then jumped by 114.38% to $25.47 in 2024, then sank by 124.93% to -$6.35 in 2025.
- Business Quant data shows PBM's EPS (Basic) at -$6.35 in Q3 2025, $25.47 in Q3 2024, and -$177.06 in Q3 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -6.35 |
| Sep 30, 2024 | 25.47 |
| Sep 30, 2023 | -177.06 |
| Mar 31, 2023 | -2,417.69 |